Wai Lung Holdings (08021): The rights issue has been validly accepted by approximately 30.41%.
Wai Lung Holdings Limited (08021) announced that by 4:00 pm on Tuesday, May 12, 2026 (the final acceptance deadline), the company has received a total of 4 valid applications submitted based on the provisional allotment letters, involving a total of 109 million shares of new shares under the rights issue, accounting for approximately 30.41% of the total number of new shares under the rights issue submitted.
Accordia Holdings Limited (08021) announced that on May 12, 2026 (Tuesday) at 4:00 pm (the final deadline), the company has received a total of 4 valid applications submitted in accordance with the provisional allotment letter, involving a total of 109 million shares of the rights issue shares. This represents approximately 30.41% of the total number of rights issue shares submitted.
Related Articles
In the first four months, the cumulative power generation of DATANG RENEW(01798) was 11.78 million megawatt hours, a year-on-year decrease of 10.08%.
SAMSONITE (01910) spent about HK$194.82 million on May 18 to repurchase 1.3272 million shares.
VISEN PHARMA-B (02561) spent HK$211,000 on May 18 to repurchase 9200 shares.
In the first four months, the cumulative power generation of DATANG RENEW(01798) was 11.78 million megawatt hours, a year-on-year decrease of 10.08%.
SAMSONITE (01910) spent about HK$194.82 million on May 18 to repurchase 1.3272 million shares.
VISEN PHARMA-B (02561) spent HK$211,000 on May 18 to repurchase 9200 shares.
